AmyBrooks-KayalMDFAAN, FAES, FANA

PubMed

• Ruxolitinib-dependent reduction of seizure load and duration is accompanied by spatial memory improvement in the rat pilocarpine model of temporal lobe epilepsy.
  Andrew Carrel, Eleonora Napoli, Kathryn Hixson, Jessica Carlsen, Yasmin Cruz Del Angel
  Neurotherapeutics. 2024-12-05
• Shifts in the spatiotemporal profile of inflammatory phenotypes of innate immune cells in the rat brain following acute intoxication with the organophosphate diisoprop...
  Peter M Andrew, Jeremy A MacMahon, Pedro N Bernardino, Yi-Hua Tsai, Brad A Hobson
  Journal of Neuroinflammation. 2024-11-04
• Neonatal Seizures.
  Emily S Stieren, Catherine A Rottkamp, Amy R Brooks-Kayal
  Neoreviews. 2024-06-01

Lectures

• Your Grant was Rejected. Now What? 
  Los Angeles, CA - 1/1/2018
• Women in Neuroscience 
  Los Angeles, CA - 1/1/2018
• Getting from Mechanisms to Therapies: New Treatments on the Horizon for Epilepsy 
  Orlando, FL, 2018; Trinidad, 2018 - 1/1/2018
• Getting from mechanism to medicine: Insights from an academic�s journey into translational epilepsy research 
  New Haven, CT, 2016; New York, NY, 2017 - 1/1/2017
• Getting from mechanism to medicine: Opportunities and Challenges in the development of new therapies for epilepsy 
  Layfayette, IN - 1/1/2017
• Epilepsy at the Cutting Edge: Using Novel Models for Therapeutic Advances 
  Boston, MA - 1/1/2017
• From Mechanism to Medicine: Modifying signaling pathways to prevent post-traumatic epilepsy 
  Denver, CO - 1/1/2017
• Neurobehavioral Co-morbidities in Pediatric Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Advances in Translational Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Epilepsy at the Cutting Edge: using novel models and innovative approaches to make therapeutic advances 
  Washington, DC - 1/1/2017
• BDNF & JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  University of Aix-Marseille, Marseille, France - 1/1/2016
• JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  Waco, TX - 1/1/2016
• Cannabinoids for Treatment of Pediatric Epilepsy: The Hype And The Evidence 
  NIH Campus, Bethesda, MD - 1/1/2016
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying Therapies for Epilepsy 
  Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA - 1/1/2016
• JAK/STAT Regulation after Brain Injury: Potential New Targets for Disease Modification 
  Breckenridge, CO - 1/1/2016
• Cannabinoids 
  Washington DC - 1/1/2015
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying and Preventative Therapies for Epilepsy 
  Boston University, Department of Pharmacology - 1/1/2015
• Comorbid Cognitive and Neuropsychiatric Disorders of Epilepsy and CNS Disorders with Seizures 
  Park City Utah - 1/1/2015
• Regulating aberrant plasticity after brain injury; following novel pathways to find new treatments 
  Taormina, Sicily, Italy - 1/1/2015
• Animal Models of Epilepsy Co-Morbidities: What do they tell us about mechanisms 
  Istanbul, Turkey - 1/1/2015
• JAK/STAT pathway activation as a molecular biomarker of epileptogenesis and cognitive co-morbidities after brain injury 
  Heybeliada Island, Istanbul, Turkey - 1/1/2015
• Strategic Planning 
  Istanbul, Turkey - 1/1/2015
• The challenge and promise of developing disease modifying therapies for epilepsy 
  Washington, DC - 1/1/2015
• BDNF and JAK/STAT regulation after brain injury: potential new targets for disease modification in epilepsy 
  Estes Park, CO - 1/1/2015
• Why make the journey: The need for disease modifying and preventative therapies for epilepsy 
  Philadelphia, PA - 1/1/2015
• Join now to see all